Hematopoietic stem cell response to acute thrombocytopenia requires signaling through distinct receptor tyrosine kinases.
Acute Disease
Animals
Becaplermin
/ metabolism
Blood Platelets
/ metabolism
Hematopoietic Stem Cells
/ metabolism
Mice, Inbred C57BL
Proto-Oncogene Proteins c-kit
/ metabolism
Receptor Protein-Tyrosine Kinases
/ metabolism
Signal Transduction
Thrombocytopenia
/ metabolism
Vascular Endothelial Growth Factor A
/ metabolism
Vascular Endothelial Growth Factor Receptor-2
/ metabolism
Journal
Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509
Informations de publication
Date de publication:
26 09 2019
26 09 2019
Historique:
received:
21
03
2019
accepted:
14
08
2019
pubmed:
23
8
2019
medline:
31
1
2020
entrez:
23
8
2019
Statut:
ppublish
Résumé
Although bone marrow niche cells are essential for hematopoietic stem cell (HSC) maintenance, their interaction in response to stress is not well defined. Here, we used a mouse model of acute thrombocytopenia to investigate the cross talk between HSCs and niche cells during restoration of the thrombocyte pool. This process required membrane-localized stem cell factor (m-SCF) in megakaryocytes, which was regulated, in turn, by vascular endothelial growth factor A (VEGF-A) and platelet-derived growth factor-BB (PDGF-BB). HSCs and multipotent progenitors type 2 (MPP2), but not MPP3/4, were subsequently activated by a dual-receptor tyrosine kinase (RTK)-dependent signaling event, m-SCF/c-Kit and VEGF-A/vascular endothelial growth factor receptor 2 (VEGFR-2), contributing to their selective and early proliferation. Our findings describe a dynamic network of signals in response to the acute loss of a single blood cell type and reveal the important role of 3 RTKs and their ligands in orchestrating the selective activation of hematopoietic stem and progenitor cells (HSPCs) in thrombocytopenia.
Identifiants
pubmed: 31434705
pii: S0006-4971(20)70789-5
doi: 10.1182/blood.2019000721
doi:
Substances chimiques
Vascular Endothelial Growth Factor A
0
Becaplermin
1B56C968OA
Proto-Oncogene Proteins c-kit
EC 2.7.10.1
Receptor Protein-Tyrosine Kinases
EC 2.7.10.1
Vascular Endothelial Growth Factor Receptor-2
EC 2.7.10.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1046-1058Informations de copyright
© 2019 by The American Society of Hematology.